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Abstract Urotensin II (UII) is a cyclic neuropeptide initially
isolated from the caudal neurosecretory system of teleost fish.
The recent cloning of the UII precursor in frog and human has
demonstrated that the peptide is not restricted to the fish
urophysis but that it is also expressed in the central nervous
system of tetrapods. Here, we describe the characterization of
the cDNAs encoding prepro-UII in mouse and rat. A comparison
of the primary structures of mouse and rat UII with those of
other vertebrate UII reveals that the sequence of the cyclic region
of the molecule (CFWKYC) has been fully conserved. In
contrast, the N-terminal flanking domain of prepro-UII has
markedly diverged with only 48% sequence identity between the
mouse or rat and the human precursors. In situ hybridization
histochemistry showed that the prepro-UII gene is predominantly
expressed in motoneurons of the brainstem and spinal cord,
suggesting that UII may play a role in the control of
neuromuscular functions.
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1. Introduction
The caudal portion of the spinal cord of teleost ¢sh incor-
porates a neurosecretory organ called the urophysis [1]. Two
neuropeptides, urotensin I (UI) and urotensin II (UII), have
been isolated from extracts of urophyses on the basis of their
ability to reduce blood pressure in rat [2] and to contract the
isolated trout intestine [3], respectively. UI is a 41-amino acid
residue peptide which belongs to a family of regulatory pep-
tides including the frog skin peptide sauvagine [4] and the
brain peptides corticotropin-releasing factor [5] and urocortin
[6]. Fish UII is a 12-amino acid residue cyclic peptide which
exhibits some structural similarities with somatostatin but is
not homologous to any other regulatory peptide identi¢ed to
date [3,7].
It has long been considered that UII was speci¢cally pro-
duced by the ¢sh urophysis [1,7]. However, the characteriza-
tion of UII from the brain of a frog [8] has shown that a
UII-encoding gene does also exist in certain species of tetra-
pods and that this gene is expressed not only in the caudal
portion of the spinal cord but also in brain neurons. The
observation that synthetic ¢sh UII could exert various spas-
mogenic e¡ects in rat and rabbit [9^11], together with the
characterization of high a⁄nity binding sites for ¢sh UII in
rat arteries [12], strongly suggested that a UII-related peptide
also existed in mammals. Indeed, we have recently identi¢ed
the cDNA encoding the UII precursor in human and we have
found that the UII gene is intensely expressed in a subset of
motoneurons in the human spinal cord [13]. This latter study
has revealed that the amino acid sequence of the cyclic
C-terminal region of UII has been totally preserved from
¢sh to human [3,8,13,14] while the sequence of the N-terminus
is highly variable [15,16]. Up to now, calcitonin gene-related
peptide (CGRP) [17] and UII are the only neuropeptides
found to occur in motoneurons of the spinal cord, suggesting
that UII could exert modulatory activities at the neuromus-
cular junction as previously shown for CGRP [18].
The UII cDNA has now been cloned from human cells [13]
but the sequence of UII has not yet been identi¢ed in other
mammalian species. In the present study, we have character-
ized the cDNAs encoding the UII precursors in mouse and rat
and we have determined the distribution of the UII mRNA in
the central nervous system (CNS) and in peripheral organs.
2. Materials and methods
2.1. Cloning of mouse and rat prepro-urotensin II (prepro-UII) cDNA
Total RNAs from mouse and rat spinal cords were extracted by the
acid guanidinium thiocyanate-phenol-chloroform procedure, using Tri
reagent (Sigma) [19]. Poly(A) RNAs were puri¢ed from total RNAs
with the PolyATract mRNA Isolation System III,IV (Promega). 1 Wg
of each poly(A) RNA was used to construct libraries of adapter-
ligated double-strand cDNAs from mouse and rat spinal cords, using
the Marathon cDNA Ampli¢cation kit (Clontech). The 5P-ends of
mouse and rat prepro-UII cDNAs were ampli¢ed by polymerase
chain reaction (PCR) using the adapter primer AP1 and UROM
(Table 1), a degenerated primer designed from the conserved cyclic
region of UII (CFWKYCV). All reactions were performed in a total
volume of 50 Wl PCR mixture containing 10 mM Tris-HCl, pH 9.0,
50 mM KCl, 0.1% Triton X-100, 1.5 mM MgCl2, 200 WM each dNTP,
1 WM each primer, 5% dimethylsulfoxide and 1.25 U Taq DNA
Polymerase (Promega), using 1 Wl of a 1:50 dilution of adapter-ligated
ds-cDNA as target. Touchdown PCR was performed successively for
¢ve cycles (denaturation at 94‡C for 5 s; annealing at 57‡C for 3 min),
¢ve cycles (denaturation at 94‡C for 5 s; annealing at 55‡C for 3 min)
and 25 cycles (denaturation at 94‡C for 5 s; annealing at 53‡C for
3 min), in a Perkin-Elmer Gene Amp PCR System 9700. The 5P-
sequence information obtained was then used to design rat (RA3)
and mouse (SOU3) prepro-UII speci¢c primers (Table 1) in order to
perform 3P-RACE reactions in the presence of the AP1 primer (denat-
uration at 94‡C for 5 s and annealing at 55‡C, for 30 cycles). The
PCR products obtained were inserted into pGEM-T vector (Promega)
and sequenced in both directions, using the Thermosequenase kit
(Amersham) in an Automated 4000L DNA Sequencer (LI-COR).
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2.2. Semi-quantitative reverse transcription-polymerase chain reaction
(RT-PCR)
Single-stranded cDNA was generated by reverse transcription (RT)
of 5 Wg total RNA extracted from several mouse and rat tissues.
RT-PCR was conducted in a 20-Wl ¢nal reaction mixture containing
25 mM Tris-HCl, pH 8.3, 37.5 mM KCl, 1.5 mM MgCl2, 50 mM
DTT, 25 Wg/ml oligo-dT15 (Promega) and 200 U SuperscriptII (Gibco
BRL). Aliquots (12.5%) of the RT reaction were then analyzed by
PCR using primer pairs designed from mouse (CCLLSOU; TRAL-
SOU) and rat (MDRVRA; LLRSRA) prepro-UII mRNA (Table 1).
The PCR conditions were similar to those described above except that
30 cycles of denaturation at 94‡C for 20 s, annealing at 55‡C for 40 s
and extension at 72‡C for 40 s were used. An internal control PCR
reaction was performed in a separate tube, using two speci¢c glycer-
aldehyde-3-phosphate dehydrogenase primers (GAPDHS, GAPD-
HAS). The ampli¢ed products were separated on 1.5% agarose gels,
blotted on nylon membranes and hybridized with an UII internal
oligonucleotide probe speci¢c for mouse (SOINT) or rat (RAINT)
prepro-UII (Table 1). The PCR products were subcloned into
pGEM-T (Promega) and sequenced on both strands by using the
Thermosequenase £uorescent labeled primer cycle sequencing kit
(Amersham).
2.3. In situ hybridization histochemistry
Rats were killed with chloral hydrate and perfused transcardially
with 4% paraformaldehyde. Frontal sections (12 Wm thick) were cut in
a cryostat and kept at 380‡C until use. Sections were pretreated as
previously described [20] and covered with pre-hybridization bu¡er
(50% formamide, 0.6 M NaCl, 10 mM Tris-HCl, pH 7.5, 0.02% Fi-
coll, 0.02% polyvinylpyrrolidone, 0.1% BSA, 1 mM EDTA, pH 8.0;
Table 1















Fig. 1. Alignment of the amino acid sequences of human, mouse, rat, frog and carp prepro-UII. The putative signal peptide sequence is indi-
cated in italics. Conserved amino acid residues are indicated in black. The dots in the sequences indicate gaps introduced for the alignment pur-
pose. The human, frog and carp prepro-UII sequences are from [13,13,15], respectively.
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550 Wg/ml denatured salmon sperm DNA, 50 Wg/ml yeast tRNA).
Sense and antisense riboprobes were prepared by in vitro transcription
of PCR products obtained with prepro-UII speci¢c primers
(CCLLSOU and TRALSOU for mouse; MDRVRA and LLRSRA
for rat) extended at the 5P-end with the SP6 and T7 RNA polymerase
promoters, in the presence of [35S]UTP (Amersham). Hybridization
was performed overnight, at 55‡C, in pre-hybridization bu¡er supple-
mented with 10 mM dithiothreitol, 10% dextran sulfate and heat-
denatured riboprobes. Post-hybridization washes were performed in
2USSC for 30 min, at 60‡C, followed by treatment with RNase A
(50 Wg/ml) for 1 h, at 37‡C, and by ¢ve ¢nal stringent washes in
0.1USSC. Sections were then dehydrated and apposed onto Hyper-
¢lm L-max (Amersham) for 2 weeks. After exposure, the slides were
dipped into Kodak NTB-2 liquid emulsion at 40‡C for 15 days and
developed. The tissue sections were counterstained with eosin and
hematoxylin to identify neuroanatomical structures.
3. Results and discussion
3.1. Cloning and characterization of mouse and rat UII
precursors
Previous studies have shown that human and frog UII
genes are intensely expressed in motoneurons of the spinal
cord [13,21]. Mouse and rat spinal cords were thus used to
prepare libraries of adapter-ligated double-stranded cDNA
from which full-length mouse and rat prepro-UII cDNAs
were isolated. The overall organization of the two rodent
UII pro-hormones is similar to those of other vertebrates
(Fig. 1). The mouse 539-bp cDNA encompasses an open read-
ing frame encoding a 123-amino acid prepro-protein including
a putative 20-residue signal peptide [22]. Two potential cleav-
age sites for pro-hormone convertases [23] are present at po-
sitions Arg85^Lys86 and Arg105^Lys106. Cleavage at the latter
dibasic site would generate a 17-residue peptide containing the
UII signature motif at its C-terminus. Two additional peptides
containing 18 and 64 residues may be generated if the up-
stream Arg85^Lys86 basic pair is used. Prepro-UII also pos-
sesses several potential monobasic cleavage sites. In particu-
lar, cleavage at the Lys109 position would have the potential to
generate a shorter 14-residue UII variant. Although cleavage
at single lysine residues is not common, the existence of a
lysine-speci¢c endopeptidase has been postulated [24].
The rat 529-bp cDNA encodes a 123-amino acid protein
which includes a 20-amino acid hydrophobic signal peptide.
Analysis of the putative processing sites revealed that the rat
UII precursor may be cleaved at three basic doublets, Arg85^
Lys86, Arg105^Arg106 and Arg108^Lys109, and thus may gener-
ate two £anking peptides containing 64 and 18 residues, in
addition to the 14-residue UII peptide. Alternatively, if the
cleavage at Arg108^Lys109 is not complete, a 17-residue form
of UII, similar to mouse UII, can be generated.
3.2. Comparison of the structures of prepro-UII among
vertebrates
Alignment of the sequence of the mouse and rat prepro-UII
proteins with the human sequence showed an overall identity
of only 48% and 47%, respectively (Table 2). In the UII re-
gion, the degree of similarity between the mouse or rat and
the human sequences was 63%. In fact, the sequence of the N-
terminal region of UII is highly variable while the cyclic do-
main located in the C-terminal region of the molecule has
been fully conserved between ¢sh and mammals [3,13,15].
Evolutionary pressure has also acted to conserve an acidic
residue (Asp or Glu) upstream of the cyclic region and a
hydrophobic residue (Val or Ile) at the C-terminus. Struc-
ture-activity relationship studies on isolated rat aorta have
shown that the C-terminal region of UII, including the acidic
and hydrophobic residues £anking the cyclic domain, is the
minimum e¡ective core which exhibits the same contractile
potency as the intact UII peptide [12]. Mouse and rat UII
possess, at their N-terminus, a Gln residue which is generally
converted during posttranslational processing into a P-Glu
residue by a glutaminyl cyclase [25,26]. The presence of an
N-terminal P-Glu residue plays an important role for the bio-
logical activity of certain neuropeptides such as thyrotropin-
releasing hormone and gonadotropin-releasing hormone [27]
but is not implicated in the activity of others including corti-
cotropin-releasing factor [5] and neurotensin [28]. Whether N-
terminal pyroglutamyl modi¢cation of mouse and rat UII is
required for the biological activity of the peptides is currently
unknown.
Table 2




Frog 25% 26% 26%
Carp K 16% 19% 22% 12%
Carp Q 16% 24% 25% 22% 89%
Human Mouse Rat Frog Carp K Carp Q
The sequences of human and frog prepro-UII are from [13]. The se-
quences of carp K prepro-UII and carp Q prepro-UII are from [15].
Sequence identity was calculated using the Clustal Program (http://
www.sanger.ac.uk/Software/EGCG/eclustalw.html).
Fig. 2. Analysis of prepro-UII mRNA distribution in several mouse (A) and rat (B) tissues by RT-PCR. Total RNA was extracted and sub-
jected to RT-PCR as described in Section 2. The PCR products were detected by hybridization with a speci¢c mouse or rat 32P-labeled oligo-
nucleotide probe. Ethidium bromide staining of GAPDH PCR products showed that equivalent amounts of mRNA were reverse-transcribed.
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3.3. Distribution of prepro-UII mRNA
The expression of the prepro-UII gene in the CNS and in
peripheral organs was studied by RT-PCR analysis. In both
mouse and rat, the strongest hybridization signals were ob-
served in the medulla oblongata and the spinal cord (Fig. 2).
A less intense ampli¢cation signal was found in the mouse
cerebellum (Fig. 2A). At the periphery, a weak signal was
detected in the mouse thymus (Fig. 2A) and in the rat epidi-
dymis (Fig. 2B). The expression pattern of the prepro-UII
gene in rodents is globally similar to that previously reported
in human [13] and frog [13,21]. Notably, in all four species of
tetrapods investigated so far, the highest concentrations of
prepro-UII mRNA are found in the medulla oblongata and
spinal cord. The occurrence of prepro-UII mRNA has also
been detected in the human thymus [13], suggesting that UII,
like many other neuropeptides, could be involved in the mod-
ulation of the immune response.
In situ hybridization histochemistry revealed that, in the rat
CNS, UII mRNA exclusively occurs in motoneurons located
in several nuclei of the medulla oblongata, including the tri-
geminal, abducens, facial, ambiguus and hypoglossal nuclei
(Fig. 3A^E), as well as in the ventral horn of the spinal
cord (Fig. 3F,G). Speci¢c expression of the prepro-UII gene
in motoneurons of the human and frog brainstem has already
been described [13] and, in frog, the UII peptide has been
characterized in spinal cord extracts [21], indicating that trans-
lation of the mRNA and processing of the precursor to gen-
erate mature UII actually occur in motoneurons. So far,
CGRP is the only other neuropeptide which has been detected
in adult motoneurons [29]. It has been shown that CGRP is
located in cholinergic terminals at the neuromuscular junction
[30]. It has also been reported that CGRP may act at the
presynaptic level by stimulating acetylcholine release from
motoneurons [31] and at the postsynaptic level by enhancing
the expression of the K-subunit of the nicotinic receptor [18].
The speci¢c expression of the prepro-UII gene in motoneu-
rons of the brainstem and spinal cord suggests that UII, like
CGRP, may exert modulatory activities at the neuromuscular
junction.
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